Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 120A2, pseudogene (abbreviated FAM120A2P), also known as C9orf129, bA165J3.3, and FAM120A2P pseudogene, is a human pseudogene with limited or no known protein-coding function.\n\nFAM120A2P encodes a pseudogene, meaning it is a genomic DNA sequence similar to a functional gene but generally considered non-functional due to accumulated mutations which prevent normal protein-coding[2][3][4]. Pseudogenes like FAM120A2P may arise from duplication or retrotransposition events. While most pseudogenes do not produce functional proteins, recent studies suggest some encode short peptides, can be transcribed into RNA, and may play regulatory roles, typically at the RNA level, such as acting as competing endogenous RNAs or regulating parental gene expression through microRNA binding[1][4][5].\n\nFAM120A2P is not established as a therapeutic target since there is no evidence of protein-coding or well-defined biological function, nor is it known to be involved in any specific disease process or interact with drugs[2][3][4]. It is best classified within \"Other\" molecular families as a non-coding or pseudogene, not in classical categories like receptors, enzymes, or transporters.\n\nWhile pseudogenes in some cases serve as sources for regulatory non-coding RNAs and may even encode short regulatory peptides, these properties are not confirmed for FAM120A2P itself. There are no associated drugs, biomarkers, or known safety concerns involving this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 120A2, pseudogene (FAM120A2P).